跳至主要内容
临床试验/NL-OMON48495
NL-OMON48495已完成3 期

GON-injection for a sooner and better treatment of cluster headache: a double-blind randomized controlled trial - CHIANTI

eids Universitair Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients have to be diagnosed with episodic cluster headache according to the
  • international classification of headache disorders - third edition, ICHD-3
  • - Patients have to be aged 18 years or older
  • - Patients need to be newly diagnosed and treatment naïve, or already diagnosed
  • and currently free from prophylactic treatment
  • - Patients need to have a mean of 1 or more attacks per day in the 3 days
  • preceding inclusion.
  • - Patients should be in their cluster period for shorter than 4 weeks before

排除标准

  • - A contraindication for treatment with steroids or verapamil
  • - The use of anticoagulants or known bleeding disorder.
  • - Use of any prophylactic medication for cluster headache
  • - Patients with a history of other primary headache who are currently using
  • prophylactic medication for this headache
  • - Pregnancy

研究者

相似试验